Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: A double blind randomized placebo controlled trial

References

• Neill KK, Luer MS. Ischemic stroke prevention: An update on antiplatelet therapy. Neurol Res 2002; 24: 381–388
   PubMed Web of Science ®Google Scholar
• Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353: 2373–2383
   PubMed Web of Science ®Google Scholar
• Yee DL, Sun CW, Bergeron AL, Dong JF, Bray PF. Aggregometry detects platelet hyperreactivity in healthy individuals. Blood 2005; 106: 2723–2729
   PubMed Web of Science ®Google Scholar
• Panzer S, Hocker L, Koren D. Agonists-induced platelet activation varies considerably in healthy male individuals: Studies by flow cytometry. Ann Hematol 2006; 85: 121–125
   PubMed Web of Science ®Google Scholar
• Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606–617
   PubMed Web of Science ®Google Scholar
• Shantsila E, Watson T, Lip GY. Aspirin resistance: What, why and when?. Thromb Res 2007; 119: 551–554
   PubMedGoogle Scholar
• Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312–319
   PubMed Web of Science ®Google Scholar
• Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000; 83: 316–321
   PubMed Web of Science ®Google Scholar
• Feuring M, Haseroth K, Janson CP, Falkenstein E, Schmidt BM, Wehling M. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100). Int J Clin Pharmacol Ther 1999; 37: 584–588
   PubMed Web of Science ®Google Scholar
• Frossard M, Fuchs I, Leitner JM, Hsieh K, Vlcek M, Losert H, Domanovits H, Schreiber W, Laggner AN, Jilma B. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 2004; 110: 1392–1397
   PubMed Web of Science ®Google Scholar
• Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin “resistance” and risk of cardiovascular morbidity: Systematic review and meta-analysis. BMJ 2008; 336: 195–198
   PubMed Web of Science ®Google Scholar
• Reny JL, De Moerloose P, Dauzat M, Fontana P. Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A systematic review and meta-analysis. J Thromb Haemost 2008; 6: 444–450
   PubMed Web of Science ®Google Scholar
• Spectre G, Brill A, Gural A, Shenkman B, Touretsky N, Mosseri E, Savion N, Varon D. new point-of-care method for monitoring anti-platelet therapy: Application of the cone and plate(let) analyzer. Platelets 2005; 16: 293–299
   PubMedGoogle Scholar
• Shenkman B, Einav Y, Salomon O, Varon D, Savion N. Testing agonist-induced platelet aggregation by the Impact-R [Cone and plate(let) analyzer (CPA)]. Platelets 2008; 19: 440–446
   PubMed Web of Science ®Google Scholar
• Schwammenthal Y, Tsabari R, Shenkman B, Schwartz R, Matetzky S, Lubetsky A, Orion D, Israeli-Korn S, Chapman J, Savion N, et al. Aspirin responsiveness in acute brain ischaemia: Association with stroke severity and clinical outcome. Cerebrovasc Dis 2008; 25: 355–361
   PubMed Web of Science ®Google Scholar
• Shenkman B, Matetzky S, Fefer P, Hod H, Einav Y, Lubetsky A, Varon D, Savion N. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests. Thromb Res 2008; 122: 336–345
   PubMedGoogle Scholar
• Smith SC, Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363–2372
   PubMed Web of Science ®Google Scholar
• Jilma B, Fuchs I. Detecting aspirin resistance with the platelet function analyzer (PFA-100). Am J Cardiol 2001; 88: 1348–1349
   PubMedGoogle Scholar
• Jilma-Stohlawetz P, Hergovich H, Homoncik M, Dzirlo L, Horvath M, Janisiw M, Panzer S, Jilma B. Impaired platelet function among platelet donors. Thromb Haemost 2001; 86: 880–886
   PubMed Web of Science ®Google Scholar
• Crescente M, Di Castelnuovo A, Iacoviello L, Vermylen J, Cerletti C, de Gaetano G. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review. Thromb Haemost 2008; 99: 14–26
   PubMed Web of Science ®Google Scholar
• Savion N, Varon D. Impact–the cone and plate(let) analyzer: Testing platelet function and anti-platelet drug response. Pathophysiol Haemost Thromb 2006; 35: 83–88
   PubMedGoogle Scholar
• Lordkipanidze M, Pharand C, Nguyen TA, Schampaert E, Palisaitis DA, Diodati JG. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J 2008; 29: 2877–2885
   PubMed Web of Science ®Google Scholar
• Tran HA, Anand SS, Hankey GJ, Eikelboom JW. Aspirin resistance. Thromb Res 2007; 120: 337–346
   PubMed Web of Science ®Google Scholar
• Chen WH, Cheng X, Lee PY, Ng W, Kwok JY, Tse HF, Lau CP. Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med 2007; 160120: 631–635
   Google Scholar
• Siller-Matula JM, Haberl K, Prillinger K, Panzer S, Lang I, Jilma B. The effect of antiplatelet drugs clopidogrel and aspirin is less immediately after stent implantation. Thromb Res. Jan 8, 2009, [Epub ahead of print]
   PubMedGoogle Scholar
• Rosin C, Brunner M, Lehr S, Quehenberger P, Panzer S. The formation of platelet-leukocyte aggregates varies during the menstrual cycle. Platelets 2006; 17: 61–66
   PubMed Web of Science ®Google Scholar
• Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003; 41: 961–965
   PubMed Web of Science ®Google Scholar